Key result
Preoperative statin use in patients with bicuspid aortic valve disease referred for surgery was associated with lower odds of ascending aortic dilatation ≥4.5 cm.
Why the study?
Does preoperative statin use reduce ascending aortic dilatation in patients with bicuspid aortic valve disease referred for surgery?
Observational (n=680)
No
Does preoperative statin use reduce ascending aortic dilatation in patients with bicuspid aortic valve disease referred for surgery?
Answers are grounded in this paper and cite their sources.
Preoperative statin use is associated with lower odds of clinically significant ascending aortic dilatation in patients with bicuspid aortic valve disease referred for surgery.
BACKGROUND: No medical therapy has been proven to prevent the progression of aortic dilatation in bicuspid aortic valve (BAV) disease, and prophylactic aortic surgery remains the mainstay of treatment. HYPOTHESIS: Among patients with BAV disease who are referred for surgery, preoperative statin use is associated with decreased odds of ascending aortic dilatation. METHODS: We reviewed all BAV patients who underwent aortic valve and/or aortic surgery at our center between April 2004 and December 2013. Aortic diameter (AD), defined as the maximum ascending aortic dimension, was determined by magnetic resonance imaging, computed tomography, or echocardiography. Patients were divided into 2 groups: maximal AD <4.5 cm or ≥4.5 cm. The association between preoperative statin use and aortic dilatation was assessed using multivariable logistic regression modeling. RESULTS: Of 680 consecutive patients, 405 (60%) had AD <4.5 cm (mean age, 60 ± 14 years; 45% on statins), whereas 275 (40%) had AD ≥4.5 cm (mean age, 54 ± 13 years; 35% on statins) at the time of surgery. After adjusting for age, body surface area, sex, hypertension, aortic stenosis, severity of aortic regurgitation, and use of angiotensin-converting enzyme inhibitors, angiotensin receptor blockers, and β-blockers, patients with AD ≥4.5 cm had 0.66× lower odds (95% confidence interval: 0.45-0.96) of being on preoperative statins compared with those with AD <4.5 cm (P = 0.029). CONCLUSIONS: In a retrospective study of BAV patients referred for surgery, preoperative statin use was associated with lower odds of clinically significant ascending aortic dilatation.
No takes yet. Share an insight, caveat, or question.
Taylor et al. (2015) conducted an observational in Bicuspid aortic valve (BAV) disease (n=680). Preoperative statin use vs. No preoperative statin use was evaluated on Ascending aortic dilatation (maximal aortic diameter ≥4.5 cm) (OR 0.66, 95% CI 0.45-0.96, p=0.029). Preoperative statin use in patients with bicuspid aortic valve disease referred for surgery was associated with lower odds of ascending aortic dilatation ≥4.5 cm.
Synapse has enriched 10 related papers. Consider them for comparative context: